Only the NICE (National Institute for Health and Care Excellence) 2009 guidelines for the diagnosis of celiac disease included the determination of antibodies against tissue transglutaminase II (anti-tTG) and antibodies against endomysium (anti-EMA). Here, TGM2 is linked to celiac disease.